Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Cited In for PubMed (Select 20305562)

1.

Serum Angiogenesis Markers and Their Correlation with Ultrasound-Detected Synovitis in Juvenile Idiopathic Arthritis.

Świdrowska J, Smolewski P, Stańczyk J, Smolewska E.

J Immunol Res. 2015;2015:741457. doi: 10.1155/2015/741457. Epub 2015 May 4.

2.

Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.

Gurol G, Ciftci IH, Harman H, Karakece E, Kamanli A, Tekeoglu I.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1979-84. eCollection 2015.

3.

Contact pathway of coagulation and inflammation.

Wu Y.

Thromb J. 2015 May 6;13:17. doi: 10.1186/s12959-015-0048-y. eCollection 2015.

4.

Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?

Noort AR, Tak PP, Tas SW.

Arthritis Res Ther. 2015 Jan 28;17:15. doi: 10.1186/s13075-015-0527-3.

5.

Association between Hepatocyte Growth Factor (HGF) Gene Polymorphisms and Serum HGF Levels in Patients with Rheumatoid Arthritis.

Kara F, Yildirim A, Gumusdere M, Karatay S, Yildirim K, Bakan E.

Eurasian J Med. 2014 Oct;46(3):176-81. doi: 10.5152/eajm.2014.41. Epub 2014 Aug 26.

6.

Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?

Witte T.

Clin Rheumatol. 2015 Apr;34(4):629-34. doi: 10.1007/s10067-015-2861-x. Epub 2015 Jan 22.

7.

Differential regulation of c-Met signaling pathways for synovial cell function.

Shibasaki S, Tsunemi S, Kitano S, Sekiguchi M, Sano H, Iwasaki T.

Springerplus. 2014 Sep 23;3:554. doi: 10.1186/2193-1801-3-554. eCollection 2014.

8.

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis.

Zhou HF, Yan H, Pan H, Hou KK, Akk A, Springer LE, Hu Y, Allen JS, Wickline SA, Pham CT.

J Clin Invest. 2014 Oct;124(10):4363-74. doi: 10.1172/JCI75673. Epub 2014 Aug 26.

9.

New radiotracers for imaging of vascular targets in angiogenesis-related diseases.

Hong H, Chen F, Zhang Y, Cai W.

Adv Drug Deliv Rev. 2014 Sep 30;76:2-20. doi: 10.1016/j.addr.2014.07.011. Epub 2014 Jul 30. Review.

PMID:
25086372
10.

NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis.

Noort AR, van Zoest KP, Weijers EM, Koolwijk P, Maracle CX, Novack DV, Siemerink MJ, Schlingemann RO, Tak PP, Tas SW.

J Pathol. 2014 Nov;234(3):375-85. doi: 10.1002/path.4403. Epub 2014 Aug 28.

11.

Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis.

Ryu JH, Chae CS, Kwak JS, Oh H, Shin Y, Huh YH, Lee CG, Park YW, Chun CH, Kim YM, Im SH, Chun JS.

PLoS Biol. 2014 Jun 10;12(6):e1001881. doi: 10.1371/journal.pbio.1001881. eCollection 2014 Jun.

12.

Characterising the expression and function of CCL28 and its corresponding receptor, CCR10, in RA pathogenesis.

Chen Z, Kim SJ, Essani AB, Volin MV, Vila OM, Swedler W, Arami S, Volkov S, Sardin LV, Sweiss N, Shahrara S.

Ann Rheum Dis. 2014 May 15. pii: annrheumdis-2013-204530. doi: 10.1136/annrheumdis-2013-204530. [Epub ahead of print]

PMID:
24833787
13.

Temporal cytokine expression and the target organ attributes unravel novel aspects of autoimmune arthritis.

Astry B, Venkatesha SH, Moudgil KD.

Indian J Med Res. 2013 Nov;138(5):717-31. Review.

14.

Norisoboldine suppresses VEGF-induced endothelial cell migration via the cAMP-PKA-NF-κB/Notch1 pathway.

Lu Q, Tong B, Luo Y, Sha L, Chou G, Wang Z, Xia Y, Dai Y.

PLoS One. 2013 Dec 9;8(12):e81220. doi: 10.1371/journal.pone.0081220. eCollection 2013.

15.

Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis.

Tsunemi S, Iwasaki T, Kitano S, Matsumoto K, Takagi-Kimura M, Kubo S, Tamaoki T, Sano H.

Arthritis Res Ther. 2013 Jul 22;15(4):R75. doi: 10.1186/ar4252.

16.

Computer-aided diagnosis of rheumatoid arthritis with optical tomography, Part 2: image classification.

Montejo LD, Jia J, Kim HK, Netz UJ, Blaschke S, Müller GA, Hielscher AH.

J Biomed Opt. 2013 Jul;18(7):076002. doi: 10.1117/1.JBO.18.7.076002.

17.
18.

Suppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticles.

Zhou HF, Yan H, Senpan A, Wickline SA, Pan D, Lanza GM, Pham CT.

Biomaterials. 2012 Nov;33(33):8632-40. doi: 10.1016/j.biomaterials.2012.08.005. Epub 2012 Aug 24.

19.

RhoB controls endothelial cell morphogenesis in part via negative regulation of RhoA.

Howe GA, Addison CL.

Vasc Cell. 2012 Feb 8;4:1. doi: 10.1186/2045-824X-4-1.

20.

Endothelial FAK as a therapeutic target in disease.

Infusino GA, Jacobson JR.

Microvasc Res. 2012 Jan;83(1):89-96. doi: 10.1016/j.mvr.2011.09.011. Epub 2011 Oct 6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk